Work

Inhibition of PLK1 Helps Restrict c-Met–Induced Growth and Therapeutic Resistance of Renal Cancer Cells

Year: 2026

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-26-0483

Authors: Laxminarayan Rawat, Chiranth M. Prakash, Yuzuru Sasamoto, Rahi Tinni Basu, Akash Sabarwal, Soumitro Pal

Institutions: Boston Children's Hospital, Harvard University, Boston Children's Museum, Brigham and Women's Hospital, The Ohio State University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Dana-Farber/Harvard Cancer Center, National Cancer Institute

OpenAlex ID: W7214111196

FWCI:

Cites:

Cited by:

Related to: